Biosimilars are making an impact in the GI field. Dr. Jennifer Caudle and Dr. Stephen Hanauer discuss the evolving role of biosimilars in anti-inflammatory care for GI patients.
Trending
- With AI and biomarkers, selfies could support doctors’ decision-making (Healthcare IT News)
- AI-Based Ambient Scribes May Reduce Physician Documentation Time, Burnout (Gastroenterology Advisor)
- ChatGPT’s AI Health-Care Push Has a Fatal Flaw (Bloomberg)
- Exploring trust factors in AI-healthcare integration: a rapid review (Frontiers in Artficial Intelligence)
- ChatGPT’s AI Health-Care Push Has a Fatal Flaw (Bloomberg)
- AI is speeding into healthcare. Who should regulate it? (The Harvard Gazette)
- Ethical and Legal Considerations for Responsible Use of AI in Clinical Gastroenterology (American Journal of Gastroenterology)
- Google Launches MedGemma 1.5 & MedASR to Broaden Healthcare AI Capabilities (Digital Health News)
